Biologics in COVID-19 so far: systematic review
M Arias, H Oliveros, S Lechtig, RH Bustos - Pharmaceuticals, 2022 - mdpi.com
This systematic review aimed to reevaluate the available evidence of the use of biologics as
treatment candidates for the treatment of severe and advanced COVID-19 disease; what are …
treatment candidates for the treatment of severe and advanced COVID-19 disease; what are …
Emergency Use of Tocilizumab in Moderate and Severe COVID‐19 Patients over the Prevaccination Stage during the Pandemic in Mexico
Y Bernal Luna, A Esquivel Loza… - Advances in …, 2022 - Wiley Online Library
Introduction. COVID‐19 has been associated with the overactivation of the immune system;
interleukin‐6 (IL‐6) seems to have a key role, which made its moderation to be proposed as …
interleukin‐6 (IL‐6) seems to have a key role, which made its moderation to be proposed as …
Predictors of poor outcomes in young non-comorbid patients with COVID-19
BA Martínez-Guerra, C Medrano-Borromeo… - Revista de …, 2022 - scielo.org.mx
Resumen MARTINEZ-GUERRA, Bernardo A. et al. Predictors of poor outcomes in young
non-comorbid patients with COVID-19. Rev. invest. clín.[online]. 2022, vol. 74, n. 5, pp. 268 …
non-comorbid patients with COVID-19. Rev. invest. clín.[online]. 2022, vol. 74, n. 5, pp. 268 …
Rural treatment of COVID-19 patients with pirfenidone, nitazoxanide and colchicine. Case series
BI Esquivel, JM Calderón, LEC Carrillo… - Monaldi Archives for …, 2023 - monaldi-archives.org
Combined treatments against SARS-CoV-2 are emerging and some have taken into account
the post-COVID-19 fibrosis. The aim of this survey was to report the experience of treating …
the post-COVID-19 fibrosis. The aim of this survey was to report the experience of treating …
Análisis de factores de riesgo y biomarcadores asociados a cuadro crítico de COVID-19
E Valdez Arias - repositorio.tec.mx
El descubrimiento del novel coronavirus 2, denominado SARS-CoV-2, causante del
síndrome respiratorio agudo severo y de la enfermedad por coronavirus 2019, llamada …
síndrome respiratorio agudo severo y de la enfermedad por coronavirus 2019, llamada …